Gastric restrictive operations for morbid obesity.

Area of Science:

• Bariatric Surgery
• Obesity Medicine
• Surgical Outcomes

Background:

• Morbid obesity presents significant health challenges, necessitating effective long-term treatment options.
• Gastric restrictive surgery has emerged as a primary intervention for managing severe obesity over the last decade.
• Comorbidities associated with morbid obesity include hypertension, diabetes, arthritis, and heart disease.

Purpose of the Study:

• To evaluate the safety and efficacy of gastric restrictive surgery for morbid obesity.
• To assess long-term outcomes, including mortality and weight loss, following bariatric procedures.
• To compare institutional results with multi-center data for gastric surgery in obese patients.

Main Methods:

• Retrospective review of 289 patients undergoing gastric surgery for morbid obesity.
• Analysis of comorbidities, operative mortality, overall mortality, and follow-up rates.
• Comparison of institutional data with a larger cohort of 5,178 patients from 12 centers.

Main Results:

• Zero operative mortality and 1% overall mortality with no deaths directly linked to the procedure.
• Significant excess weight loss of 50-64% observed 4-6 years post-surgery.
• A low treatment failure rate of 5% at 12-18 months postoperatively.
• Operative and late mortality rates comparable to the general nonobese population.

Conclusions:

• Gastric restrictive surgery is a safe and effective treatment for morbid obesity.
• The procedure leads to substantial and sustained weight loss.
• Bariatric surgery significantly reduces health risks associated with severe obesity.